Remifentanil dosing in low-weight ICU patients
Treatments studied
Part of Pain clinical trials.
This study looks at how the sedative remifentanil works in critically ill patients who are underweight or normal weight. It aims to find the right dose for these patients while they are on a breathing machine in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You are underweight (BMI below 18.5) or normal weight (BMI between 18.5 and 24).
- You are currently in the intensive care unit (ICU).
- You need a breathing machine (ventilator) for more than 10 hours.
- You are not pregnant and do not have a severe breathing problem or allergy to remifentanil.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to manage sedation (medication to keep you calm and comfortable) for people on a breathing machine. The goal is to see if adjusting sedation based on your breathing effort leads to better outcomes and shorter time on the machine.
This study compares two types of sedation (medicine to keep you calm and comfortable) for people in the intensive care unit (ICU) who need a breathing machine. It looks at which approach is more cost-effective and may help guide better care.
This study tests a combination of two sedative drugs (remazolam besylate and remifentanil) for calming patients with sepsis who are on a ventilator in the ICU. The goal is to see if this approach improves recovery compared to standard care.
This study tests a pain medicine called hydromorphone to see how well it controls pain in ICU patients on breathing machines. The goal is to make patients more comfortable while they are recovering.
This study tests how a pain-relief medication called remifentanil changes the way your body responds to pressure pain. Researchers will measure your pain sensitivity before and after receiving this medication to better understand how it works.
This study tests whether a sedative medication called remimazolam helps patients on breathing machines (ventilators) in the ICU recover better and have fewer complications. You would receive this medication to keep you calm and comfortable while on the ventilator.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.